MENU
+Compare
GEVO
Stock ticker: NASDAQ
AS OF
Dec 18, 03:23 PM (EDT)
Price
$1.58
Change
+$0.01 (+0.64%)
Capitalization
175.4M

GEVO stock forecast, quote, news & analysis

GEVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
A.I.Advisor
a Summary for GEVO with price predictions
Dec 17, 2024

GEVO sees its Stochastic Oscillator ascends from oversold territory

On December 11, 2024, the Stochastic Oscillator for GEVO moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 67 instances where the indicator left the oversold zone. In of the 67 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where GEVO's RSI Indicator exited the oversold zone, of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 17, 2024. You may want to consider a long position or call options on GEVO as a result. In of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GEVO just turned positive on November 29, 2024. Looking at past instances where GEVO's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GEVO advanced for three days, in of 225 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day moving average for GEVO crossed bearishly below the 50-day moving average on November 14, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GEVO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for GEVO entered a downward trend on December 02, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GEVO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.315) is normal, around the industry mean (3.612). P/E Ratio (42.017) is within average values for comparable stocks, (34.004). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.088). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (10.121) is also within normal values, averaging (92.747).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GEVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Dow (NYSE:DOW), DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 8.96B. The market cap for tickers in the group ranges from 47 to 223.16B. LIN holds the highest valuation in this group at 223.16B. The lowest valued company is GTBT at 47.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was -2%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -5%. SNES experienced the highest price growth at 46%, while VBVBF experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was 23%. For the same stocks of the Industry, the average monthly volume growth was 23% and the average quarterly volume growth was 60%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 61
Price Growth Rating: 62
SMR Rating: 76
Profit Risk Rating: 81
Seasonality Score: 20 (-100 ... +100)
View a ticker or compare two or three
GEVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a company which engages in the development and commercialization of alternatives to petroleum-based products

Industry ChemicalsSpecialty

Profile
Fundamentals
Details
Industry
Chemicals Specialty
Address
345 Inverness Drive South
Phone
+1 303 858-8358
Employees
103
Web
https://www.gevo.com